A new tool CovReport generates easy-to-understand sequencing coverage summary for diagnostic reports.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
10 04 2020
Historique:
received: 04 12 2019
accepted: 20 03 2020
entrez: 12 4 2020
pubmed: 12 4 2020
medline: 15 12 2020
Statut: epublish

Résumé

In order to properly interpret the results of a diagnostic gene panel sequencing test, gene coverage needs to be taken into consideration. If coverage is too low, an additional re-sequencing test is needed to make sure that a pathogenic variant is not missed. To facilitate the interpretation of coverage data, we designed CovReport, a novel easy-to-use visualization tool. CovReport generates a concise coverage summary that allows one-glance assessment of the sequencing test performance. Both gene-level and exon-level coverage can be immediately appreciated and taken into consideration for further medical decisions. CovReport does not require complex installation and can thus be easily implemented in any diagnostic laboratory setting. A user-friendly interface generates a graphic summary of coverage that can be directly included in the diagnostic report. In addition to a stand-alone version, we also provide a command line version of CovReport that can be integrated into any bioinformatics pipeline. This flexible tool is now part of routine sequencing analysis at the Department of Medical Genetics at La Timone Hospital (Marseille, France). CovReport is available at http://jdotsoft.com/CovReport.php. It is implemented in Java and supported on Windows, Mac OS X and Linux.

Identifiants

pubmed: 32277129
doi: 10.1038/s41598-020-63079-4
pii: 10.1038/s41598-020-63079-4
pmc: PMC7148332
doi:

Substances chimiques

Connectin 0
TTN protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6247

Références

Ebbert, M. T. W. et al. Systematic analysis of dark and camouflaged genes reveals disease-relevant genes hiding in plain sight. Genome Biol. 20, 97 (2019).
doi: 10.1186/s13059-019-1707-2
Desvignes, J.-P. et al. VarAFT: a variant annotation and filtration system for human next generation sequencing data. Nucleic Acids Res. 46, W545–W553 (2018).
doi: 10.1093/nar/gky471
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
doi: 10.1093/bioinformatics/btq033
Quinlan, A. R. BEDTools: The Swiss-Army Tool for Genome Feature Analysis. Current Protocols in Bioinformatics vol. 47 11.12.1–11.12.34 (2014).
Krahn, M. et al. A National French consensus on gene lists for the diagnosis of myopathies using next-generation sequencing. Eur. J. Hum. Genet. 27, 349–352 (2019).
doi: 10.1038/s41431-018-0305-1
Gorokhova, S. et al. Comparing targeted exome and whole exome approaches for genetic diagnosis of neuromuscular disorders. Appl Transl Genom 7, 26–31 (2015).
doi: 10.1016/j.atg.2015.07.006
Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032–2034 (2015).
doi: 10.1093/bioinformatics/btv098
Pedersen, B. S. & Quinlan, A. R. Mosdepth: quick coverage calculation for genomes and exomes. Bioinformatics 34, 867–868 (2018).
doi: 10.1093/bioinformatics/btx699
Doig, K. D. et al. PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories. Genome Med. 9, 38 (2017).
doi: 10.1186/s13073-017-0427-z
Münz, M. et al. CoverView: a sequence quality evaluation tool for next generation sequencing data. Wellcome Open Res 3, 36 (2018).
doi: 10.12688/wellcomeopenres.14306.1

Auteurs

Mark Gorokhov (M)

JDotSoft, Germantown, MD, USA.

Mathieu Cerino (M)

Aix Marseille University, INSERM, MMG, U1251, Marseille, France.
Department of Medical Genetics, La Timone Hospital, AP-HM, Marseille, France.
Laboratory of Biochemistry, La Conception Hospital, AP-HM, Marseille, France.

Jérémie Mortreux (J)

Aix Marseille University, INSERM, MMG, U1251, Marseille, France.
Department of Medical Genetics, La Timone Hospital, AP-HM, Marseille, France.

Florence Riccardi (F)

Aix Marseille University, INSERM, MMG, U1251, Marseille, France.
Department of Medical Genetics, La Timone Hospital, AP-HM, Marseille, France.

Nicolas Lévy (N)

Aix Marseille University, INSERM, MMG, U1251, Marseille, France.
Department of Medical Genetics, La Timone Hospital, AP-HM, Marseille, France.

Marc Bartoli (M)

Aix Marseille University, INSERM, MMG, U1251, Marseille, France.

Martin Krahn (M)

Aix Marseille University, INSERM, MMG, U1251, Marseille, France.
Department of Medical Genetics, La Timone Hospital, AP-HM, Marseille, France.

Svetlana Gorokhova (S)

Aix Marseille University, INSERM, MMG, U1251, Marseille, France. svetlana.gorokhova@univ-amu.fr.
Department of Medical Genetics, La Timone Hospital, AP-HM, Marseille, France. svetlana.gorokhova@univ-amu.fr.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH